Literature DB >> 21546968

Locking out hepatitis C.

Gisa Gerold, Charles M Rice.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21546968     DOI： 10.1038/nm0511-542

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  13 in total

1.  Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes.

Authors:  Isabel Fofana; Sophie E Krieger; Fritz Grunert; Sandra Glauben; Fei Xiao; Samira Fafi-Kremer; Eric Soulier; Cathy Royer; Christine Thumann; Christopher J Mee; Jane A McKeating; Tatjana Dragic; Patrick Pessaux; Francoise Stoll-Keller; Catherine Schuster; John Thompson; Thomas F Baumert
Journal:  Gastroenterology       Date:  2010-06-02       Impact factor: 22.682

Review 2.  New HCV therapies on the horizon.

Authors:  J Vermehren; C Sarrazin
Journal:  Clin Microbiol Infect       Date:  2011-02       Impact factor: 8.067

3.  Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors.

Authors:  Andrew J Syder; Haekyung Lee; Mirjam B Zeisel; Joe Grove; Eric Soulier; James Macdonald; Stephine Chow; Julia Chang; Thomas F Baumert; Jane A McKeating; Jeffrey McKelvy; Flossie Wong-Staal
Journal:  J Hepatol       Date:  2010-08-21       Impact factor: 25.083

4.  Expression of transforming growth factor-alpha mRNA in livers of patients with chronic viral hepatitis and hepatocellular carcinoma.

Authors:  Y H Chung; J A Kim; B C Song; G C Lee; M S Koh; Y S Lee; S G Lee; D J Suh
Journal:  Cancer       Date:  2000-09-01       Impact factor: 6.860

5.  Binding of hepatitis C virus to CD81.

Authors:  P Pileri; Y Uematsu; S Campagnoli; G Galli; F Falugi; R Petracca; A J Weiner; M Houghton; D Rosa; G Grandi; S Abrignani
Journal:  Science       Date:  1998-10-30       Impact factor: 47.728

6.  The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells.

Authors:  Thorsten Eierhoff; Eike R Hrincius; Ursula Rescher; Stephan Ludwig; Christina Ehrhardt
Journal:  PLoS Pathog       Date:  2010-09-09       Impact factor: 6.823

Review 7.  Hepatitis C and liver transplantation: enhancing outcomes and should patients be retransplanted.

Authors:  Elizabeth C Verna; Robert S Brown
Journal:  Clin Liver Dis       Date:  2008-08       Impact factor: 6.126

8.  The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Authors:  Elisa Scarselli; Helenia Ansuini; Raffaele Cerino; Rosa Maria Roccasecca; Stefano Acali; Gessica Filocamo; Cinzia Traboni; Alfredo Nicosia; Riccardo Cortese; Alessandra Vitelli
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

9.  Hepatitis C virus-induced up-regulation of protein phosphatase 2A inhibits histone modification and DNA damage repair.

Authors:  Francois H T Duong; Verena Christen; Shanshan Lin; Markus H Heim
Journal:  Hepatology       Date:  2010-03       Impact factor: 17.425

10.  Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.

Authors:  Alexander Ploss; Matthew J Evans; Valeriya A Gaysinskaya; Maryline Panis; Hana You; Ype P de Jong; Charles M Rice
Journal:  Nature       Date:  2009-01-28       Impact factor: 49.962
View more
  2 in total

1.  Hepatitis C virus and lipid profiles: more questions than answers?

Authors:  Ching-Sheng Hsu; Jia-Horng Kao
Journal:  Hepatol Int       Date:  2011-07-29       Impact factor: 6.047

2.  Quantitative Proteomics Identifies Serum Response Factor Binding Protein 1 as a Host Factor for Hepatitis C Virus Entry.

Authors:  Gisa Gerold; Felix Meissner; Janina Bruening; Kathrin Welsch; Paula M Perin; Thomas F Baumert; Florian W Vondran; Lars Kaderali; Joseph Marcotrigiano; Abdul G Khan; Matthias Mann; Charles M Rice; Thomas Pietschmann
Journal:  Cell Rep       Date:  2015-07-23       Impact factor: 9.423
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.